These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8322453)

  • 1. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
    Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
    Ogawa T; Yorioka N; Yamakido M
    Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of thyroid cancer cells by complement-regulatory factors.
    Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
    Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
    Takahashi T; Inaba S; Okada T
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
    Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
    Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy.
    Miyamoto H; Yoshioka K; Takemura T; Akano N; Maki S
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):77-86. PubMed ID: 3131958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.
    Falk RJ; Podack E; Dalmasso AP; Jennette JC
    Am J Pathol; 1987 Apr; 127(1):182-90. PubMed ID: 2952015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.
    Gerl VB; Bohl J; Pitz S; Stoffelns B; Pfeiffer N; Bhakdi S
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1104-8. PubMed ID: 11923252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis.
    Garred P; Lyon H; Christoffersen P; Mollnes TE; Tranum-Jensen J
    Liver; 1993 Dec; 13(6):305-10. PubMed ID: 7507546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
    PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of C3 cleavage fragments, factor H, and the C5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant.
    Cosyns JP; Kazatchkine MD; Bhakdi S; Mandet C; Grossetete J; Hinglais N; Bariety J
    Clin Nephrol; 1986 Oct; 26(4):203-8. PubMed ID: 2946502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
    Wilson HR; Medjeral-Thomas NR; Gilmore AC; Trivedi P; Seyb K; Farzaneh-Far R; Gunnarsson I; Zickert A; Cairns TD; Lightstone L; Cook HT; Pickering MC
    Kidney Int; 2019 Mar; 95(3):655-665. PubMed ID: 30655025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis.
    Niculescu F; Rus HG; Vlaicu R
    Atherosclerosis; 1987 May; 65(1-2):1-11. PubMed ID: 2955791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda.
    Vasil KE; Magro CM
    J Am Acad Dermatol; 2007 Jan; 56(1):96-104. PubMed ID: 17190626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
    Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
    Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.
    Murphy BF; Davies DJ; Morrow W; d'Apice AJ
    Pathology; 1989 Oct; 21(4):275-8. PubMed ID: 2483750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.
    Koffler D; Biesecker G; Noble B; Andres GA; Martinez-Hernandez A
    J Exp Med; 1983 Jun; 157(6):1885-905. PubMed ID: 6343549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement Activation in Kidneys of Patients With COVID-19.
    Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2020; 11():594849. PubMed ID: 33584662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.